Trial Profile
An open-label, randomized, three-treatment, three-period, crossover study to investigate mutual drug-drug interactions between ACT-064992 and sildenafil in healthy male subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Aug 2014
Price :
$35
*
At a glance
- Drugs Macitentan (Primary) ; Sildenafil
- Indications Eisenmenger complex; Erectile dysfunction; Female infertility; Glioblastoma; Idiopathic pulmonary fibrosis; Pulmonary arterial hypertension; Raynaud's disease; Skin ulcer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 14 Aug 2014 New trial record